Cargando…

Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs

BACKGROUND: Insurers manage the cost of specialty medicines via rebates, however it is unclear if the savings are passed on to patients, and whether reducing rebates may lead to changes in patient out-of-pocket (OOP) costs and medication adherence. This study examined two drug classes to understand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, William Bruce, Seetasith, Arpamas, Hung, Anna, Zullig, Leah L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851557/ https://www.ncbi.nlm.nih.gov/pubmed/36656871 http://dx.doi.org/10.1371/journal.pone.0280570

Ejemplares similares

Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018
por: Lakdawalla, Darius, et al.
Publicado: (2021)

Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018
por: Yeung, Kai, et al.
Publicado: (2021)

Argumentación rebatible : modelos y aplicaciones
por: Bodanza, Gustavo Adrián
Publicado: (2011)

Contextualizing the Price of Biosimilar Adalimumab Based on Historical Rebates for the Original Formulation of Branded Adalimumab
por: Dickson, Sean R., et al.
Publicado: (2023)

Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial
por: Bilger, Marcel, et al.
Publicado: (2019)

Association of Out-of-Pocket Pharmacy Costs with Adherence to Varenicline
por: Suehs, Brandon T., et al.
Publicado: (2014)

Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part D
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Patients’ access to drugs with rebates in Switzerland – Empirical analysis and policy implications for drug pricing in Europe
por: Carl, David L, et al.
Publicado: (2021)

Claim for Rebate of Spirit Duty
por: Churchfield, Jas. M.
Publicado: (1917)

Implications of drugs with rebate in Europe
por: Bonetti, Andrea, et al.
Publicado: (2021)

Physicians’ Rebate Check-Book
Publicado: (1892)

Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
por: Rome, Benjamin N., et al.
Publicado: (2021)

Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis
por: Fox, David, et al.
Publicado: (2022)

Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019
por: Clemans-Cope, Lisa, et al.
Publicado: (2023)

Real price of health-experiences of out-of-pocket costs in Australia: protocol for a systematic review
por: Wang, Shelley Ting-Li, et al.
Publicado: (2022)

The duration of cost-cutting effects of price-lists
por: Schilling, Ulf Martin
Publicado: (2010)

Premium Rebates and the Quiet Consensus on Market Reform for Medicare
por: Feldman, Roger, et al.
Publicado: (2001)

Pressure on Pharmacy Benefit Managers for Disclosure and Demonstration of Value - Rebates and Drug Benegit Cost Savings
por: Curtiss, Frederic R.
Publicado: (2003)

Cutting costs – the impact of price-lists on the cost development in the emergency department
por: Schilling, Ulf Martin
Publicado: (2009)

Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder
por: Seetasith, Arpamas, et al.
Publicado: (2019)

Adherence rates and health care costs in Crohn’s disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis of patient claims and home health nurse data
por: Wolf, Douglas C, et al.
Publicado: (2018)

Discounts and rebates granted to public payers for medicines in European countries
por: Vogler, Sabine, et al.
Publicado: (2012)

Paediatric genomic testing: Navigating medicare rebatable genomic testing
por: Sachdev, Rani, et al.
Publicado: (2021)

Out of Pocket Costs and Variation in Panniculectomy Procedures
por: Oleru, Olachi, et al.
Publicado: (2023)

The Promise of Specialty Pharmaceuticals: Are They Worth the Price?
por: Sullivan, Sean D.
Publicado: (2008)

Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes
por: Bibeau, Wendy S., et al.
Publicado: (2016)

Out-of-pocket expenditure and drug adherence of patients with diabetes in Odisha
por: Swain, Swagatika Priyadarshini, et al.
Publicado: (2018)

The Relative Value of Disease Management Programs Versus Drug Manufacturer Rebates
por: Curtiss, Frederic R.
Publicado: (2003)

Trends in Out-of-Pocket Cost of Glucagon, 2010-2020
por: Zupa, Margaret, et al.
Publicado: (2022)

Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence
por: Galaznik, Aaron, et al.
Publicado: (2014)

Trends in Pricing and Out-of-Pocket Spending on Entecavir Among Commercially Insured Patients, 2014-2018
por: Alpern, Jonathan D., et al.
Publicado: (2022)

Estimated costs of production and potential prices for the WHO Essential Medicines List
por: Hill, Andrew M, et al.
Publicado: (2018)

Association of Out-of-Pocket Spending With Insulin Adherence in Medicare Part D
por: Trish, Erin, et al.
Publicado: (2021)

Footing the bill: the introduction of Medicare Benefits Schedule rebates for podiatry services in Australia
por: Short, Anthony J
Publicado: (2009)

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates
por: Espin, Jaime, et al.
Publicado: (2018)

Out-of-pocket costs and adherence to antihypertensive agents among older adults covered by the public drug insurance plan in Quebec
por: Milan, Raymond, et al.
Publicado: (2017)

Out-of-pocket costs for paediatric admissions in district hospitals in Kenya
por: Barasa, Edwine W, et al.
Publicado: (2012)

Are patients willing to incur out of pocket costs for pharmacogenomic testing?
por: Bielinski, Suzette J., et al.
Publicado: (2016)

Analysis of out-of-pocket costs associated with hospitalised injuries in Vietnam
por: Nguyen, Ha, et al.
Publicado: (2017)

Internal Medicine Trainee Understanding and Reaction to Out of Pocket Costs
por: Chidester, Jeffrey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_stepg5e5lu4hrovanjjuh7g1fr